Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.

Authors:
Ankur Goyal
Ankur Goyal
All India Institute of Medical Sciences
New Delhi | India
Amit Prasad
Amit Prasad
Sanjay Gandhi Postgraduate Institute of Medical Sciences
India
Sapna Gupta
Sapna Gupta
Fox Chase Cancer Center
Ujjala Ghoshal
Ujjala Ghoshal
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow | India
Archana Ayyagari
Archana Ayyagari
Sanjay Gandhi Postgraduate Institute of Medical Sciences
India

Indian J Med Res 2009 Jun;129(6):695-700

Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Background & Objective: Extended spectrum beta-lactamases (ESBLs) have emerged as a major threat worldwide with limited treatment options. The genotypes of ESBL producing strains largely remain unknown in India; hence the present study was aimed to determine the occurrence of ESBLs in Escherichia coli and Klebsiella pneumoniae, their molecular types and associated risk factors in a tertiary care hospital.

Methods: Total 200 consecutive clinical isolates of E. coli (n=143) and K. pneumoniae (n=57) collected between February and July 2006 at Sanjay Gandhi Postgraduate Institute of Medical Sciences, a tertiary care hospital in north India, were examined phenotypically for ESBL production. ESBL strains were further typed for the bla(TEM/SHV/CTX-M) genes by PCR using specific primers. The bla(CTX-M) cluster was identified by restriction analysis and genotype by sequencing of PCR product. Resistance to other antimicrobial agents was also studied. Various risk factors associated with ESBL infections were analyzed by logistic regressions.

Results: ESBLs were found in 63.6 per cent E. coli and 66.7 per cent K. pneumoniae isolates. Majority of the typeable isolates harboured two or more ESBL genes (57.3%). Overall bla(CTX-M) was the commonest genotype (85.4%) followed by bla(TEM) (54.9%) and bla(SHV) (32.9%) either alone or in combination. All CTX-M enzymes in E. coli and 87.5 per cent in K. pneumoniae belonged to the CTX-M-1 cluster. Sequencing was done for randomly selected 20 bla(CTX-M) PCR products and all were identified as CTXM- 3. Resistance of ESBL isolates to other antibiotics was amikacin 14.7 per cent, gentamicin 66.7 per cent, trimethoprim/sulphamethoxazole 79.1 per cent and ciprofloxacin 93.8 per cent. Prior antibiotic exposure, use of intravenous device and urinary catheter, renal insufficiency and ICU admission were associated with ESBL infection on univariate analysis. On multivariate, antibiotic exposure (P=0.001) and use of urinary catheter (P<0.001) were identifified as risk for ESBL infection.

Interpretation & Conclusion: Our study showed high ESBL occurrence with CTX-M as the emerging type in our hospital and CTX-M-3 being reported for the fi rst time in India. High co-resistance to other non-beta-lactam antibiotics is a major challenge for management of ESBL infections.

Download full-text PDF

Source
June 2009
15 Reads

Publication Analysis

Top Keywords

risk factors
12
cent pneumoniae
8
klebsiella pneumoniae
8
associated risk
8
tertiary care
8
antibiotic exposure
8
urinary catheter
8
coli klebsiella
8
associated esbl
8
extended spectrum
8
spectrum beta-lactamases
8
667 cent
8
escherichia coli
8
cent
7
esbl
7
pneumoniae
5
coli
5
esbl strains
4
875 cent
4
production esbl
4

Similar Publications

CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.

Braz J Infect Dis 2012 Sep-Oct;16(5):420-5. Epub 2012 Sep 8.

Universidad de Córdoba, Institute for Tropical Biological Research, Monteria, Colombia.

Objective: Describe the presence of CTX-M-1 phylogenetic subgroup extended-spectrum β-lactamases (ESBL), associated with TEM and SHV genes, and the gene encoding cephalosporinase, CMY-2 in Escherichia coli and Klebsiella pneumoniae isolates from community-acquired urinary tract infections.

Methods: 102 E. coli and 21K. Read More

View Article
April 2013

Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.

J Med Assoc Thai 2011 Dec;94(12):1504-12

Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Background: Resistance to beta-lactams has been increasing in the treatment of infections caused by Escherichia coli and Klebsiella pneumoniae. The production of extended-spectrum beta-lactamases (ESBLs), that hydrolyze extended-spectrum cephalosporins, is the major cause of beta-lactam resistance.

Objective: To determine the prevalence and characterize of ESBLs produced by E. Read More

View Article
December 2011

Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.

J Microbiol Immunol Infect 2012 Jun 12;45(3):193-9. Epub 2012 May 12.

Division of Infectious Diseases, Department of Internal Medicine, Cathay General Hospital, Taipei City, Taiwan.

Background: Extended-spectrum β-lactamase (ESBL)-producing bacteria coexpressing AmpC type β-lactamase (ACBL) are associated with the laboratory issue of false susceptibility to third-generation cephalosporins. This study was to evaluate laboratory tests and clinical significance of bacteremic isolates of Escherichia coli and Klebsiella pneumoniae with both ESBL and ACBL [dual-type lactamases (DTL)].

Methods: From 2006 to 2009, 78 E coli and 12 pneumoniae bacteremic isolates with reduced susceptibility to cefotaxime (CTX) or ceftazidime (CAZ) were identified and relevant patients' data were collected for analysis. Read More

View Article
June 2012

Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.

Antimicrob Agents Chemother 2008 Aug 27;52(8):2818-24. Epub 2008 May 27.

Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Prannok Rd., Bangkok-Noi, Bangkok 10700, Thailand.

Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae have rapidly spread worldwide and pose a serious threat for health care-associated (HA) infection. We conducted molecular detection and characterization of ESBL-related bla genes, including bla(TEM), bla(SHV), bla(CTX-M), bla(VEB), bla(OXA), bla(PER), and bla(GES), among 362 isolates of ESBL-producing E. coli (n = 235) and ESBL-producing K. Read More

View Article
August 2008